Gene Name |
heat shock protein 90kDa alpha (cytosolic), class A member 1 |
telomerase reverse transcriptase |
Image |
|
|
Gene Ontology Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
- Rifabutin
- Nedocromil
- 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine
- Geldanamycin
- 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine
- 9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine
- 4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid
- 17-Dmag
- 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine
- 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine
- Adenosine-5\'-Diphosphate
- 9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine
- 4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole
- 9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine
- 9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine
- 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine
- 8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine
- 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine
- N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE
- N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE
- 4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL
- 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE
- 5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide
- 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE
- 2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide
- 4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL
- (3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one
- 6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE
- 3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE
- N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE
- 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE
- 4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol
- 4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL
- 4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol
- 8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE
- 4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine
- (5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime
- 8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-
- 4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol
- 2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol
- 2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide
- 4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine
- 4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine
- 3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE
- 2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE
|
|
Diseases |
|
|
GWAS |
|
|
Protein-Protein Interactions |
130 interactors:
AHR
AHSA1
AHSA2
AIP
AIPL1
AKT1
AKT2
APAF1
APOB
AR
ARNTL
ASGR1
BIRC5
BRMS1
CALM1
CDC37
CDC37L1
CDK5R1
CDKN2A
CERS2
CFTR
CHEK1
CHUK
CKS1B
CKS2
CRNKL1
CSNK2A1
CSNK2A2
DAP3
DNAJC7
EIF2AK1
EIF2AK2
EIF2AK3
EPAS1
EPRS
ERBB2
ERN1
ESR1
FAM162A
FANCA
FANCC
FKBP4
FKBP5
FKBP6
FYN
GNA12
GSK3B
GUCY1B3
GZMA
HDAC6
HIF1A
HIF3A
HSPA1A
HSPA8
IKBKB
IKBKE
IKBKG
IP6K2
IRAK1
IRF3
JUN
KDR
LCK
LSM1
MAP3K14
MAP3K3
MAPK1
MCF2
MIS12
MMP2
MS4A2
MTRNR2L1
MYC
MYOD1
NDRG1
NOS1
NOS3
NPAS2
NR2C2
NR3C1
NR3C2
NSL1
PAK1
PDPK1
PIM1
PMF1
PPARA
PPARD
PPID
PPIL2
PPP5C
PRKCA
PRKCD
PRKDC
PTGDS
PTGES3
RAF1
RIPK1
RPS3
RPS3A
RUNX1T1
SGTA
SIM1
SKP1
SLC2A4
SLC34A1
SMYD2
SMYD3
SNCA
SRC
ST13
STARD13
STAT3
STIP1
STUB1
SUGT1
SVIL
TBK1
TERT
TJP1
TNFRSF1A
TOMM34
TOMM40
TOMM70A
TP53
UBE2N
UCHL1
USP19
USP50
WASL
|
51 interactors:
ABL1
ACAA2
AKT1
ANXA2
ATP5B
C19orf40
CCT5
CIB1
DDX51
DYNLL1
DYRK2
EIF2S1
ENO1
GLA
HSP90AA1
HSPA4
IREB2
MCRS1
MDM2
MTOR
NCL
PABPC1
PBK
PFDN1
PHF20L1
PINX1
PPIA
PRKCA
PTGES3
RELA
RPS6KB1
RUVBL1
RUVBL2
SERBP1
SLC7A11
SMG5
SMG6
SRC
STEAP4
TEP1
TERF1
TGFBR2
TIMM21
TPP1
TUBA1B
U2SURP
XPO1
XRCC5
XRCC6
YWHAQ
YWHAZ
|
Entrez ID |
3320 |
7015 |
HPRD ID |
00777 |
01754 |
Ensembl ID |
ENSG00000080824
|
ENSG00000164362
|
Uniprot IDs |
K9JA46
P07900
Q86SX1
|
O14746
|
PDB IDs |
1BYQ
1OSF
1UY6
1UY7
1UY8
1UY9
1UYC
1UYD
1UYE
1UYF
1UYG
1UYH
1UYI
1UYK
1UYL
1YC1
1YC3
1YC4
1YER
1YES
1YET
2BSM
2BT0
2BUG
2BYH
2BYI
2BZ5
2C2L
2CCS
2CCT
2CCU
2CDD
2FWY
2FWZ
2H55
2JJC
2K5B
2QF6
2QFO
2QG0
2QG2
2UWD
2VCI
2VCJ
2WI1
2WI2
2WI3
2WI4
2WI5
2WI6
2WI7
2XAB
2XDK
2XDL
2XDS
2XDU
2XDX
2XHR
2XHT
2XHX
2XJG
2XJJ
2XJX
2XK2
2YE2
2YE3
2YE4
2YE5
2YE6
2YE7
2YE8
2YE9
2YEA
2YEB
2YEC
2YED
2YEE
2YEF
2YEG
2YEH
2YEI
2YEJ
2YI0
2YI5
2YI6
2YI7
2YJW
2YJX
2YK2
2YK9
2YKB
2YKC
2YKE
2YKI
2YKJ
3B24
3B25
3B26
3B27
3B28
3BM9
3BMY
3D0B
3EKO
3EKR
3FT5
3FT8
3HEK
3HHU
3HYY
3HYZ
3HZ1
3HZ5
3INW
3INX
3K97
3K98
3K99
3MNR
3O0I
3OW6
3OWB
3OWD
3Q6M
3Q6N
3QDD
3QTF
3R4M
3R4N
3R4O
3R4P
3R91
3R92
3RKZ
3RLP
3RLQ
3RLR
3T0H
3T0Z
3T10
3T1K
3T2S
3TUH
3VHA
3VHC
3VHD
4AIF
4AWO
4AWP
4AWQ
4B7P
4EEH
4EFT
4EFU
4EGH
4EGI
4EGK
4FCP
4FCQ
4FCR
4HY6
4JQL
|
2BCK
4B18
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
alphascreen
ammp
calnexin
cndp2
combines
hspa5
hspa9
identifier
imbalance
itraq
nfhcc
nonfibrotic
nontumor
p4hb
pdia6
phosphoproteomics
pointed
proteomexchange
proteomics
proteostasis
pxd001253
resident
ser583
txn
ubc
unraveling
vcp
|
5alpha
butyl
chlorinated
cholestane
coprostanol
dihydrocholesterol
epicoprostanol
ether
experiment
extraction
fid
final
gc
internal
involves
limit
liquid
methanol
method
microg
namely
quantification
recovery
reextraction
saponification
silylation
solvents
sterols
urine
|
Tagcloud (Difference) ? |
alphascreen
ammp
calnexin
cndp2
combines
hspa5
hspa9
identifier
imbalance
itraq
nfhcc
nonfibrotic
nontumor
p4hb
pdia6
phosphoproteomics
pointed
proteomexchange
proteomics
proteostasis
pxd001253
resident
ser583
txn
ubc
unraveling
vcp
|
5alpha
butyl
chlorinated
cholestane
coprostanol
dihydrocholesterol
epicoprostanol
ether
experiment
extraction
fid
final
gc
internal
involves
limit
liquid
methanol
method
microg
namely
quantification
recovery
reextraction
saponification
silylation
solvents
sterols
urine
|
Tagcloud (Intersection) ? |
|